Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE.

JAMA. 1999 Oct 6;282(13):1240-6.

PMID:
10517426
[PubMed - indexed for MEDLINE]
2.

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG.

JAMA. 2000 Feb 23;283(8):1016-24.

PMID:
10697061
[PubMed - indexed for MEDLINE]
3.

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.

Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG.

N Engl J Med. 1999 Oct 28;341(18):1336-43.

PMID:
10536125
[PubMed - indexed for MEDLINE]
Free Article
4.

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.

Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK.

JAMA. 1996 Jan 24-31;275(4):295-9.

PMID:
8544269
[PubMed - indexed for MEDLINE]
5.

Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.

Barroso L, Treanor J, Gubareva L, Hayden FG.

Antivir Ther. 2005;10(8):901-10.

PMID:
16430195
[PubMed - indexed for MEDLINE]
6.

Oseltamivir: a review of its use in influenza.

McClellan K, Perry CM.

Drugs. 2001;61(2):263-83. Review. Erratum in: Drugs 2001;61(6):775.

PMID:
11270942
[PubMed - indexed for MEDLINE]
7.

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).

Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD002744. doi: 10.1002/14651858.CD002744.pub4. Review.

PMID:
22513907
[PubMed - indexed for MEDLINE]
8.

Neuraminidase inhibitors for preventing and treating influenza in children.

Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD002744. doi: 10.1002/14651858.CD002744.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD002744.

PMID:
22258949
[PubMed - indexed for MEDLINE]
9.

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.

Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, Jackson HC, Huson L, Ward P, Oxford JS; Oseltamivir Post Exposure Prophylaxis Investigator Group.

JAMA. 2001 Feb 14;285(6):748-54.

PMID:
11176912
[PubMed - indexed for MEDLINE]
10.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, Thompson MJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD008965.

PMID:
22258996
[PubMed - indexed for MEDLINE]
11.

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.

Fry AM, Goswami D, Nahar K, Sharmin AT, Rahman M, Gubareva L, Azim T, Bresee J, Luby SP, Brooks WA.

Lancet Infect Dis. 2014 Feb;14(2):109-18. doi: 10.1016/S1473-3099(13)70267-6. Epub 2013 Nov 22.

PMID:
24268590
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K.

N Engl J Med. 1997 Sep 25;337(13):874-80.

PMID:
9302301
[PubMed - indexed for MEDLINE]
Free Article
13.

[Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial].

Kashiwagi S, Kudoh S, Watanabe A, Yoshimura I.

Kansenshogaku Zasshi. 2000 Dec;74(12):1062-76. Japanese.

PMID:
11193558
[PubMed - indexed for MEDLINE]
14.

[Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial].

Kashiwagi S, Kudoh S, Watanabe A, Yoshimura I.

Kansenshogaku Zasshi. 2000 Dec;74(12):1044-61. Japanese.

PMID:
11193557
[PubMed - indexed for MEDLINE]
15.

Neuraminidase inhibitors: zanamivir and oseltamivir.

McNicholl IR, McNicholl JJ.

Ann Pharmacother. 2001 Jan;35(1):57-70. Review.

PMID:
11197587
[PubMed - indexed for MEDLINE]
16.

Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection.

Calfee DP, Peng AW, Cass LM, Lobo M, Hayden FG.

Antimicrob Agents Chemother. 1999 Jul;43(7):1616-20.

PMID:
10390212
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Neuraminidase inhibitors for preventing and treating influenza in children.

Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A.

Cochrane Database Syst Rev. 2003;(3):CD002744. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD002744.

PMID:
12917931
[PubMed - indexed for MEDLINE]
18.

Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection.

Sugaya N, Ohashi Y.

Antimicrob Agents Chemother. 2010 Jun;54(6):2575-82. doi: 10.1128/AAC.01755-09. Epub 2010 Apr 5.

PMID:
20368393
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.

Jefferson T, Jones M, Doshi P, Del Mar C.

BMJ. 2009 Dec 8;339:b5106. doi: 10.1136/bmj.b5106. Review.

PMID:
19995812
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pharmacokinetic-pharmacodynamic determinants of oseltamivir efficacy using data from phase 2 inoculation studies.

Rayner CR, Bulik CC, Kamal MA, Reynolds DK, Toovey S, Hammel JP, Smith PF, Bhavnani SM, Van Wart SA, Ambrose PG, Forrest A.

Antimicrob Agents Chemother. 2013 Aug;57(8):3478-87. doi: 10.1128/AAC.02440-12. Epub 2013 May 13.

PMID:
23669386
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk